Front Month Nymex Crude Rose 2.30% This Week to Settle at $80.06 — Data Talk
Front Month Nymex Crude for June delivery gained $1.80 per barrel, or 2.30% to $80.06 this week
--Largest one week net and percentage gain since the week ending April 5, 2024
--Up for two consecutive weeks
--Up $1.95 or 2.50% over the last two weeks
--Largest two week net and percentage gain since the week ending April 12, 2024
--Up three of the past four weeks
--Today it is up 83.00 cents or 1.05%
--Largest one day dollar and percentage gain since Monday, May 13, 2024
--Up for three consecutive sessions
--Up $2.04 or 2.61% over the last three sessions
--Largest three day dollar and percentage gain since Thursday, April 4, 2024
--Up six of the past eight sessions
--Highest settlement value since Tuesday, April 30, 2024
--Off 14.54% from its 52-week high of $93.68 hit Wednesday, Sept. 27, 2023
--Up 19.28% from its 52-week low of $67.12 hit Monday, June 12, 2023
--Rose 11.89% from 52 weeks ago
--Off 7.88% from its 2024 settlement high of $86.91 hit Friday, April 5, 2024
--Up 13.75% from its 2024 settlement low of $70.38 hit Tuesday, Jan. 2, 2024
--Off 44.90% from its record high of $145.29 hit Thursday, July 3, 2008
--Month-to-date it is down 2.28%
--Year-to-date it is up $8.41 or 11.74%
All prices are calculated based on the settlement price of the current front month contract.
Source: Dow Jones Market Data
(END) Dow Jones Newswires
May 17, 2024 15:07 ET (19:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks